Kirjallinen kysymys syöpälääkkeiden Kela-korvauksista

This procedure involves a written question submitted to the Finnish Parliament regarding the reimbursement system for cancer medications managed by Kela. It aims to address concerns about how much financial support patients receive for essential cancer treatments. The inquiry affects cancer patients in Finland and healthcare policymakers. It seeks to ensure equality in access to life-saving treatments by examining the adequacy of current drug reimbursement levels.